OLD National Bancorp IN Sells 1,411 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

OLD National Bancorp IN lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,358 shares of the medical equipment provider’s stock after selling 1,411 shares during the period. OLD National Bancorp IN’s holdings in Intuitive Surgical were worth $1,470,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. OFI Invest Asset Management acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $25,000. Baystate Wealth Management LLC lifted its stake in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. Headinvest LLC acquired a new position in shares of Intuitive Surgical in the third quarter worth approximately $28,000. Stone House Investment Management LLC lifted its stake in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 50 shares during the period. Finally, Truvestments Capital LLC lifted its stake in shares of Intuitive Surgical by 137.2% in the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 59 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.7 %

NASDAQ ISRG opened at $368.93 on Tuesday. The firm has a market capitalization of $130.77 billion, a P/E ratio of 66.59, a PEG ratio of 5.69 and a beta of 1.36. The business has a fifty day simple moving average of $386.57 and a 200 day simple moving average of $344.41. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.00 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have issued reports on ISRG. Robert W. Baird dropped their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday. Mizuho increased their price target on Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Royal Bank of Canada increased their price target on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Raymond James increased their price target on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Finally, Barclays increased their price target on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a report on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $396.17.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $397.07, for a total value of $2,001,629.87. Following the completion of the transaction, the vice president now owns 110 shares in the company, valued at approximately $43,677.70. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Intuitive Surgical news, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $397.07, for a total value of $2,001,629.87. Following the sale, the vice president now owns 110 shares of the company’s stock, valued at approximately $43,677.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the sale, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. In the last 90 days, insiders sold 248,418 shares of company stock worth $95,927,097. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.